Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
AIDS (London, England)
|
March 21, 2003
Sorting out the complexities of HIV-1 fitness
Eric J Arts, Miguel E Quiñones-Mateu
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 18, 2003
Fitness of drug resistant HIV-1: methodology and clinical implications
Miguel E Quiñones-Mateu, Eric J Arts
FEMS Microbiology Reviews
|
September 21, 2022
New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?
Emmanuel Ndashimye, Paul S Reyes, Eric J Arts
AIDS Research and Therapy
|
September 13, 2017
Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses
Trina Racine, Gary P Kobinger, Eric J Arts
Nature Reviews. Microbiology
|
January 5, 2007
Is HIV-1 evolving to a less virulent form in humans?
Kevin K Ariën, Guido Vanham, Eric J Arts
Journal of Virology
|
November 9, 2012
HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120
Annette N Ratcliff, Wuxian Shi, Eric J Arts
Current Opinion in HIV and AIDS
|
March 25, 2011
HIV-1 replicative fitness in elite controllers
Michael A Lobritz, Kara G Lassen, Eric J Arts
Viruses
|
October 14, 2011
HIV-1 Entry, Inhibitors, and Resistance
Michael A Lobritz, Annette N Ratcliff, Eric J Arts
AIDS Reviews
|
August 19, 2007
HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?
Denis M Tebit, Immaculate Nankya, Eric J Arts, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 3, 2005
A yeast recombination-based cloning system to produce chimeric HIV-1 viruses and express HIV-1 genes
Dawn M Moore, Eric J Arts, Yong Gao, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
AIDS (London, England)
|
March 21, 2003
Sorting out the complexities of HIV-1 fitness
Eric J Arts, Miguel E Quiñones-Mateu
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 18, 2003
Fitness of drug resistant HIV-1: methodology and clinical implications
Miguel E Quiñones-Mateu, Eric J Arts
FEMS Microbiology Reviews
|
September 21, 2022
New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?
Emmanuel Ndashimye, Paul S Reyes, Eric J Arts
AIDS Research and Therapy
|
September 13, 2017
Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses
Trina Racine, Gary P Kobinger, Eric J Arts
Nature Reviews. Microbiology
|
January 5, 2007
Is HIV-1 evolving to a less virulent form in humans?
Kevin K Ariën, Guido Vanham, Eric J Arts
Journal of Virology
|
November 9, 2012
HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120
Annette N Ratcliff, Wuxian Shi, Eric J Arts
Current Opinion in HIV and AIDS
|
March 25, 2011
HIV-1 replicative fitness in elite controllers
Michael A Lobritz, Kara G Lassen, Eric J Arts
Viruses
|
October 14, 2011
HIV-1 Entry, Inhibitors, and Resistance
Michael A Lobritz, Annette N Ratcliff, Eric J Arts
AIDS Reviews
|
August 19, 2007
HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?
Denis M Tebit, Immaculate Nankya, Eric J Arts, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 3, 2005
A yeast recombination-based cloning system to produce chimeric HIV-1 viruses and express HIV-1 genes
Dawn M Moore, Eric J Arts, Yong Gao, et al.
Page
of 12